Возраст домена | 23 года |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | 10 |
Страниц в Google | 280 |
Страниц в Яндексе | 66 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 874853 |
Alexa Country | 12510 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
ICON plc | Clinical Research Organisation (CRO) for Drug Development
n/a
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries.
UTF-8
58.33 КБ
991
8 035 симв.
6 899 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
facebook.com | 9 | 9 |
0 | 3 | 3 | |
pro-newsletter.com | 6 | 4 |
0 | 14872644 | Нет данных | |
mapi-trust.org | 6 | 5 |
0 | 434880 | 220749 | |
linkedin.com | 6 | 9 |
0 | 25 | 10 | |
pedsql.org | 5 | 4 |
0 | 3252035 | Нет данных | |
proz.com | 4 | 6 |
275 | 10001 | 12595 | |
wikipedia.org | 4 | 9 |
0 | 5 | 6 | |
mapi.net | 4 | 5 |
10 | 2770667 | Нет данных | |
mapi.com | 4 | 5 |
10 | 172227 | 22431 | |
mapivalues.com | 4 | 3 |
0 | Нет данных | Нет данных | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 25 Августа 2013 ) | |
Количество ссылок на сайт | 53 |
Количество доменов, которые ссылаются на сайт | 9 |
Количество найденных анкоров | 6 |
Исходящие (внешние) ссылки домена | 95 |
Количество доменов, на которые ссылается сайт | 10 |
Количество исходящих анкоров | 6 |
Внешние ссылки главной страницы ( 12 ) | |
webinars.iconplc.com/ | On-Demand Webinars Visit the Webinar Channel |
theconferenceforum.org/conferences/patients-as-partners-euro... | Patients as Partners Europe 27 - 28 January, 2020 |
careers.iconplc.com/ | Jobs & Careers |
investor.iconplc.com/ | Investors |
iconplc.com/services/clinical-research-services/site-and-pat... | Patients |
investor.iconplc.com/financials-filings/annual-reports | Results & Reports |
iconplc.com/study-volunteers | Volunteers |
investor.iconplc.com/ | Investors |
linkedin.com/company/icon-plc-2 | |
twitter.com/ICONplc | |
facebook.com/icon.plc.profile | |
youtube.com/user/ICONPlc | Youtube |
Внутренние ссылки главной страницы ( 101 ) | |
# | - |
/services/ | Services |
/services/adaptive-trials/ | Adaptive Trials |
/services/clinical-research-services/ | Clinical Research Services Integrated services that cover planning, management, execution and analysis. |
/services/consulting/ | Consulting |
/services/early-phase/ | Early Phase |
/services/functional-services-provision/ | Functional Services Provision |
/services/laboratories/ | Laboratories |
/services/language-services/ | Language Services |
/services/imaging/ | Medical Imaging |
/services/real-world-intelligence/ | Real World Intelligence |
/services/value-access-outcomes/ | Value Access Outcomes |
/services/clinical-research-services/site-and-patient-recrui... | Site & Patient Solutions Transforming recruitment through patient-centric trials and real-world, real-time data |
/sectors/ | Sectors |
/sectors/biosimilars/ | Biosimilars ICON can support product design, development and registration, regulatory support and commercialisation of Biosimil... |
/sectors/biotech/ | Biotech ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset ... |
/sectors/government-and-public-health-solutions/ | Government & Public Health Solutions |
/sectors/medical-device/ | Medical Device |
/sectors/pharma/ | Pharmaceuticals |
/sectors/medical-device/regulatory-affairs/eu-regulations_md... | EU MDR/IVDR Regulations The new EU medical and in vitro diagnostic device regulations go into effect at the start of 2020. Are y... |
/insights/value-based-healthcare/making-sense-of-the-biosimi... | Making sense of the Biosimilars market Strategies and recommendations to achieve optimal market access. |
/therapeutics/ | Therapeutics |
/therapeutics/cardiovascular/ | Cardiovascular |
/therapeutics/central-nervous-system/ | Central Nervous System |
/therapeutics/endocrine-metabolic-disorders/ | Endocrine & Metabolic Disorders |
/therapeutics/genomics/ | Genomics |
/therapeutics/infectious-diseases/ | Infectious Diseases |
/therapeutics/internal-medicine-and-immunology/ | Internal Medicine & Immunology |
/therapeutics/medical-device/ | Medical Device |
/therapeutics/ophthalmology/ | Ophthalmology |
/therapeutics/rare-and-orphan-diseases/ | Rare & Orphan Diseases |
/therapeutics/transplant-immunology/ | Transplant Immunology |
/therapeutics/womens-health/ | Women's Health |
/therapeutics/oncology/ | Oncology ICON has conducted hundreds of clinical studies in both solid and haematological tumours, including experience with CAR... |
/therapeutics/vaccines/ | Vaccines ICON has recently led the development of 14 vaccines resulting in FDA/EMA approvals. |
/innovation/ | Innovation |
/innovation/firecrest/ | FIRECREST |
/innovation/Intel-Pharma-Analytics/ | Intel Pharma Analytics Platform |
/innovation/drug-safety-reporting-solution/ | Drug Safety Reporting Solution |
/innovation/one-search/ | One Search |
/innovation/evidence-platform/ | Evidence Platform |
/innovation/flex-advantage/ | FLEX ADVANTAGE |
/innovation/imaging-technology/ | Medical Imaging Technology |
/innovation/nonmem/ | NONMEM |
/innovation/ICONIK/ | ICONIK |
/innovation/pdx-pop/ | PDx-POP |
/innovation/imra/ | IMRA |
/innovation/pubshub/ | PubsHub |
/innovation/addplan/ | ADDPLAN® Using data to design, simulate, and analyse adaptive clinical trials with ease. |
/innovation/patient-engagement-platform/ | Patient Engagement Portal Connecting patients with the right trial in the right location. |
/insights/ | Insights |
/insights/digital-disruption/ | Digital Disruption |
/insights/patient-centricity/ | Patient Centricity |
/insights/transforming-trials/ | Transforming Trials |
/insights/value-based-healthcare/ | Value Based Healthcare |
/insights/blog/ | Blog |
/insights/videos/ | Videos |
/insights/digital-disruption/mHealth-wearables/ | mHealth & Wearables Remote monitoring and leveraging wearable devices and sensors in clinical trials. |
/insights/digital-disruption/real-world-data/ | Real World Data Reduce post market study costs with Real World Data. |
/news-events/ | News & Events |
/news-events/press-releases/ | Press Releases |
/news-events/thought-leadership/ | In the News |
/news-events/events/ | Events |
/news-events/mediakit/ | Mediakit |
/news-events/social-media/ | ICON on social media |
/news-events/awards/ | Awards |
/about/ | About ICON |
/about/company-history/ | Company History |
/about/icon-in-asia-pacific/ | ICON in Asia Pacific |
/about/icon-in-latin-america/ | ICON in Latin America |
/about/leadership/executive-management/ | Leadership |
/about/our-quality/ | Quality We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities. |
/about/icon-and-you/ | ICON and You Partners Making a Difference. |
/investigators/ | Investigators |
/contact/ | Contact us |
index.xml?&Language=en | EN |
index.xml?&Language=ja | 日本語 |
/insights/patient-centricity/developing-nurse-centric-medica... | Read the whitepaper |
/insights/digital-disruption/digital-disruption-in-biopharma... | Read the whitepaper |
/insights/transforming-trials/increasing-complexity-and-decl... | Read the report |
/insights/value-based-healthcare/payer-reliance-on-icer-asse... | Read the whitepaper |
/services/laboratories/harness-the-power-of-flow-cytomery-to... | Flow Cytometry for Driving Trials Forward Engage assay experts with deep experience and expertise. |
/insights/patient-centricity/charting-the-managed-access-pro... | Charting the Managed Access Program Landscape Plan for regulatory and operational challenges in managed access programs. |
/insights/digital-disruption/ai-and-clinical-trials/impact-o... | The Impact of AI on Outcomes Based Contracting Understanding formulary decision maker & manufacturer challenges |
/therapeutics/central-nervous-system/key-considerations-in-c... | Key Considerations in Chronic Pain Clinical Trials Determine the right design, assessments and endpoints in your pain study |
/services/functional-services-provision/functional-resourcin... | Functional Resourcing From recruitment of a single clinical professional to managing entire global functions. |
/insights/blog/2019/11/25/healthcare-resource-use-and-costs-... | 03 December 2019 Healthcare Resource Use and Costs in AML Patients Undergoing Stem Cell Transplantation ISPOR EU 2019 WINNER -... |
/insights/blog/2019/11/27/innovation-in-oncology-drug-develo... | 27 November 2019 Innovation in Oncology Drug Development Significant progress has been made in our understanding of the molec... |
/insights/blog/2019/09/26/top-five-digital-technologies-tran... | 22 November 2019 Top Five Digital Technologies Set to Transform Pharma R&D The current wave of emerging digital technologies o... |
/insights/blog/2019/10/02/the-impact-of-digital-technology-o... | 19 November 2019 The Impact of Digital Technology on Patient Engagement in Clinical Trials The use of digital technology in cl... |
/insights/blog/2019/11/15/payers-report-that-icer-analyses-i... | 15 November 2019 Payers Report that ICER Analyses Increasingly Guide US Price Negotiations According to a survey conducted by... |
/insights/blog/2019/10/24/4-challenges-to-successful-rare-di... | 14 November 2019 Four Challenges to Successful Rare Disease Drug Development Overcoming these challenges can greatly improve c... |
/insights/blog/2019/09/19/harnessing-big-data | 01 November 2019 Harnessing Big Data: The raw material of digital transformation The integration and mastery of digital techno... |
/insights/blog/2019/10/28/challenges-and-advances-in-nash-cl... | 31 October 2019 Challenges and Advances in NASH Clinical Trials NASH is massively under-diagnosed, partly because it is a si... |
/insights/blog/2019/10/31/mdr-ivdr-regulatory-roundup | 29 October 2019 MDR / IVDR Regulatory Roundup Less than one year remains before the European Union’s new Medical Device Regul... |
/disclaimer/ | Disclaimer |
/privacy/ | Privacy |
/site-cookies/ | Site Cookies |
/contact/submit-rfp/ | Submit proposal request |
/preferences/ | Update Email Preferences |
/contact/global-office-locator/ | Global office locator |
Domain Name: MAPIGROUP.COM
Registry Domain ID: 33289945_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2018-08-22T08:55:36Z
Creation Date: 2000-08-21T08:58:28Z
Registry Expiry Date: 2019-08-21T08:58:28Z
Registrar: Network Solutions, LLC.
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: BRIT.NS.CLOUDFLARE.COM
Name Server: CORY.NS.CLOUDFLARE.COM
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-10-10T22:29:58Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
США - Индианаполис - 209.43.39.187
IQuest Internet
IQuest Internet
HTTP/1.1 200 OK
Accept-Ranges: bytes
Cache-control: no-cache="set-cookie"
Content-Type: text/html; charset=UTF-8
Date: Tue, 17 Dec 2019 16:50:20 GMT
ETag: "bf3cf40be211c20019510e3a7e42115b"
Expires: Mon, 17 Dec 2018 10:50:20 GMT
Last-Modified: Tue, 17 Dec 2019 16:50:20 GMT
Server: Roxen
Set-Cookie: AWSELB=CB9DA3E70E32836717257EE63CF891E0239CAB8B07A3554C7CF4E3DFE2784815B0166488A92B6C62D5EB8AF58D0624109D42EC6E1F60FFDCE7058A7E290DF4186ECF83B183;PATH=/
Vary: *
X-Frame-Options: deny
X-XSS-Protection: 1; mode = block
Content-Length: 59729
Connection: keep-alive
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"